Stay updated with breaking news from Quality Management Maturity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA Commissioner Robert Califf addressed the nation's drug and medical supply shortages, outlining the role the FDA is taking to address them at a meeting with
FDA unveils a plan to incentivize drugmakers to invest in quality measures, which could reduce drug shortages.
There continues to be a correlation between low site inspection scores and potential drug recalls, states the US OPQ's 2022 annual report.
Generic sterile injectable (GSI) drugs are the staple of hospital care but are particularly prone to shortages driven by market dynamics. Marta Wosińska and Richard G. Frank propose policies that foster greater manufacturing reliability in GSI drug production.
The introduction of pharmaceutical manufacturing quality ratings by the FDA under its Quality Management Maturity (QMM) programme has the potential to reduce drug shortages and improve pharmaceutical company financial performance. Here, Dr Clifford Rossi of the University of Maryland explains.